Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congressmen Call On GAO To Update Behind-The-Counter Class Investigation

This article was originally published in The Tan Sheet

Executive Summary

The Government Accountability Office should update its 1995 study of behind-the-counter drug regulatory schemes in o0ther countries to better educate FDA as it considers a third class of drugs in the U.S., members of the House Energy and Commerce Committee say in a Jan. 16 letter to the GAO
Advertisement

Related Content

Behind-The-Counter Class Requires Investment, With Payoff Unclear– GAO
Behind-The-Counter Class Requires Investment, With Payoff Unclear– GAO
BTC Proponents Cite Pharmacists’ Role; Opponents Question Need
BTC Proponents Cite Pharmacists’ Role; Opponents Question Need
Von Eschenbach Promotes Behind-The-Counter Drug Class
Advertisement
UsernamePublicRestriction

Register

PS101292

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel